Morgan Stanley lowered the firm’s price target on Teradyne (TER) to $81 from $112 and keeps an Underweight rating on the shares. Teradyne held their investor day on March 11 and the firm had a chance to host Advantest CEO Doug Lefever and Co-CCRO Sanjeev Mohan for a breakfast on March 13, notes the analyst, who contrasts comments from Teradyne’s event with the firm’s meeting with Advantest. Following both, the firm has revised down estimates for Teradyne to reflect a slower recovery path for key end-markets including auto, industrial and mobile, the analyst tells investors.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TER:
- Teradyne participates in a conference call with JPMorgan
- Teradyne price target lowered to $105 from $140 at Northland
- Teradyne price target lowered to $110 from $140 at Baird
- Strategic Acquisitions and Market Positioning Drive Buy Rating for Teradyne
- Teradyne price target lowered to $100 from $130 at Citi
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue